Weidong Wei

633 total citations
21 papers, 450 citations indexed

About

Weidong Wei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weidong Wei has authored 21 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Weidong Wei's work include RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Weidong Wei is often cited by papers focused on RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Weidong Wei collaborates with scholars based in China and Sweden. Weidong Wei's co-authors include Shuwei Liang, Zhuojia Chen, Guanmin Jiang, Yan Zhou, Qiao Su, Jun Du, Hongsheng Wang, Ning Lv, Yanan Kong and Anli Yang and has published in prestigious journals such as Cancer Research, Frontiers in Immunology and Advanced Science.

In The Last Decade

Weidong Wei

21 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weidong Wei China 13 240 187 138 68 55 21 450
Charlotte Andrieu France 8 207 0.9× 154 0.8× 178 1.3× 116 1.7× 38 0.7× 12 441
José Roberto Fígaro Caldeira Brazil 10 358 1.5× 170 0.9× 192 1.4× 68 1.0× 28 0.5× 13 512
María C. Díaz Flaqué Argentina 14 299 1.2× 108 0.6× 314 2.3× 96 1.4× 52 0.9× 23 627
Cristian P. Moiola Spain 18 421 1.8× 285 1.5× 157 1.1× 85 1.3× 79 1.4× 28 681
Yu‐Chen Pei China 9 300 1.3× 228 1.2× 158 1.1× 30 0.4× 100 1.8× 14 502
Lina Albitar United States 10 204 0.8× 99 0.5× 117 0.8× 59 0.9× 46 0.8× 12 374
Dachuan Huang Singapore 12 267 1.1× 93 0.5× 143 1.0× 63 0.9× 95 1.7× 20 488
Qicong Luo China 13 464 1.9× 261 1.4× 158 1.1× 30 0.4× 92 1.7× 22 656
Matias Casás‐Selves United States 8 350 1.5× 126 0.7× 175 1.3× 33 0.5× 71 1.3× 9 549
Liwen Zhang China 12 311 1.3× 257 1.4× 83 0.6× 24 0.4× 48 0.9× 25 509

Countries citing papers authored by Weidong Wei

Since Specialization
Citations

This map shows the geographic impact of Weidong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Wei more than expected).

Fields of papers citing papers by Weidong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weidong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Wei. The network helps show where Weidong Wei may publish in the future.

Co-authorship network of co-authors of Weidong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Wei. A scholar is included among the top collaborators of Weidong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Wei. Weidong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Shu‐Mei, Dongni Shi, Shuqin Dai, et al.. (2025). RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic–nuclear shuttling in human triple‐negative breast cancer. Clinical and Translational Medicine. 15(2). e70203–e70203. 4 indexed citations
2.
Zhang, Chao, Wenjing Zhong, Yunyun Tang, et al.. (2024). POP1 Facilitates Proliferation in Triple-Negative Breast Cancer via m6A-Dependent Degradation of CDKN1A mRNA. Research. 7. 472–472. 36 indexed citations
3.
Zhang, Chao, et al.. (2024). Peripheral NK cell count predicts response and prognosis in breast cancer patients underwent neoadjuvant chemotherapy. Frontiers in Immunology. 15. 1437193–1437193. 5 indexed citations
4.
Tian, W. H., Hailin Tang, Chao Zhang, et al.. (2024). RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer. Journal of Advanced Research. 72. 333–351. 18 indexed citations
5.
Zhang, Chao, Lijun Zeng, Wenjing Zhong, et al.. (2024). TBL2 Promotes Tumorigenesis via PRMT5/WDR77‐Mediated AKT Activation in Breast Cancer. Advanced Science. 11(47). e2400160–e2400160. 7 indexed citations
6.
Zhou, Fuqun, et al.. (2023). Regulations of Exosomal-Transmitted AFAP1-AS1 LncRNA on Ovarian Cancer Cell Migration and Invasion. Discovery Medicine. 35(178). 877–877. 2 indexed citations
7.
Tian, W. H., Yuhui Tang, Yanan Kong, et al.. (2023). Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration. International Journal of Biological Sciences. 19(5). 1645–1663. 20 indexed citations
8.
Tian, W. H., Chao Zhang, Jindong Xie, et al.. (2022). Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature. Frontiers in Immunology. 13. 1056680–1056680. 15 indexed citations
9.
Yang, Yaping, Weidong Wei, Liang Jin, et al.. (2022). Comparison of the Characteristics and Prognosis Between Very Young Women and Older Women With Breast Cancer: A Multi-Institutional Report From China. Frontiers in Oncology. 12. 783487–783487. 15 indexed citations
10.
Jian, Yunting, Hongyi Xu, Yawei Shi, et al.. (2022). Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple‐negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta. Clinical and Translational Medicine. 12(1). e725–e725. 14 indexed citations
11.
Jian, Yunting, Xinjian Huang, Lishan Fang, et al.. (2021). Actin-like protein 6A/MYC/CDK2 axis confers high proliferative activity in triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 56–56. 17 indexed citations
12.
Zhang, Kaiming, Tian Du, Yan Wang, et al.. (2021). A Novel Systematic Oxidative Stress Score Predicts the Prognosis of Patients with Operable Breast Cancer. Oxidative Medicine and Cellular Longevity. 2021(1). 9441896–9441896. 24 indexed citations
13.
Ye, Feng, Jiahuai Wen, Anli Yang, et al.. (2021). The Influence of Hormone Therapy on secondary diabetes mellitus in Breast Cancer: A Meta-analysis. Clinical Breast Cancer. 22(1). e48–e58. 15 indexed citations
14.
Li, Ning, Shaoquan Zheng, Zhenchong Xiong, et al.. (2021). Expression and prognostic value of transcription-associated cyclin-dependent kinases in human breast cancer. Aging. 13(6). 8095–8114. 3 indexed citations
15.
Liu, Peng, Yutian Zou, Xing Li, et al.. (2020). circGNB1 Facilitates Triple-Negative Breast Cancer Progression by Regulating miR-141-5p-IGF1R Axis. Frontiers in Genetics. 11. 193–193. 49 indexed citations
16.
Chen, Bo, Xiaojia Huang, Weidong Wei, Hailin Tang, & Xiaoming Xie. (2018). Abstract 520: circEPSTI1 as a prognostic marker and mediator of triple-negative breast cancer progression. Cancer Research. 78(13_Supplement). 520–520. 1 indexed citations
17.
Liang, Shuwei, Zhuojia Chen, Guanmin Jiang, et al.. (2016). Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Cancer Letters. 386. 12–23. 112 indexed citations
18.
Xie, Zeming, Xi Wang, Huan‐Xin Lin, et al.. (2014). Breast-Conserving Therapy: A Viable Option for Young Women with Early Breast Cancer—Evidence from a Prospective Study. Annals of Surgical Oncology. 21(7). 2188–2196. 7 indexed citations
19.
He, Ni, Chuanmiao Xie, Weidong Wei, et al.. (2012). A new, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer. European Journal of Radiology. 81(10). 2602–2612. 58 indexed citations
20.
Xie, Xinhua, Jiaoli Guo, Yanan Kong, et al.. (2011). Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy. The Journal of Gene Medicine. 13(12). 680–691. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlotte Andrieu Breakdown of academic impact, for papers by José Roberto Fígaro Caldeira Breakdown of academic impact, for papers by María C. Díaz Flaqué Breakdown of academic impact, for papers by Cristian P. Moiola Breakdown of academic impact, for papers by Yu‐Chen Pei Breakdown of academic impact, for papers by Lina Albitar Breakdown of academic impact, for papers by Dachuan Huang Breakdown of academic impact, for papers by Qicong Luo Breakdown of academic impact, for papers by Matias Casás‐Selves Breakdown of academic impact, for papers by Liwen Zhang
Rankless by CCL
2026